Ann: Half Yearly Report, page-74

I don't get this stock. I just don't get it. How is it only worth 100 Million (AUD I might add = like 70 Million USD) when it has virtually no debt, 19 Million in cash. Selling to 135 centres world wide, it has patents, solid intellectual property, based on solid science, and the potential of a brand new vaccine that cures the world of genital herpes? 100 Million barley buys you a mansion on Sydney harbour these days. This to me is an anomaly. I just don't get it. Why can't management sell this story? There is an absolute flood of superannuation capital out there.. Trillions of dollars. 100 Million is a drop in the ocean for these guys. Like the wrong fat finger press on a stock like AHZ and nobody in a big insto would care. So what on earth is stopping our insto's (let alone OS investors) buying this stock? What in their investment "rules" or guidance or philosophy prevents them? Is this stock bad for your health? Is it bad for the environment? Is there political risk? Is their any debt? Why aren't institutions buying it on market?